Session 797: Manifestations of cancer

Date: 1 February 2004, Time: 14:00 - 16:00
Location: Room 3

Oral Presentations

Time	Number	Title / Authors / Affiliations
14:00	281	Immunohistochemical detection of telomerase (hTERT) and c-kit in serous ovarian neoplasia: a clinicopathological study H Brustmann MD PhD Department of Pathology, Thermenklinikum, Moedling/Vienna, Austria
14:20	282	Morphologically similar normal and hyperplastic mammary ductal cells associated with and without malignant lesions have a different immunohistochemical profile YG Man MD PhD, PE Berg PhD, R Barner MD, TN Vinh MD, DT Wheeler MD, CY Liang MD, BL Strauss MD Department of Gynecologic and Breast Pathology, Armed Forces Institute of Pathology and George Washington University Medical Center, Washington, DC, United States
14:35	283	Cytotoxic effects of fumonisin B₁ on the ultrastructure of a human oesophageal carcinoma cell line - an in vitro study RB Myburg, MMS; N Singh, MMS; *AA Chuturgoon, PhD Mycotoxin Research Unit, Nelson R Mandela School of Medicine, Faculty of Health Sciences, University of Natal, Congella, Durban, South Africa
14:50	284	Mitochondrial DNA damage in non-melanoma skin cancer MA Birch-Machin^a, SE Durham^a, K Krishnan^a, J Maki^b, R Parr^b, RE Thayer^b ^aDermatology, University of Newcastle, Newcastle upon Tyne, United Kingdom, ^bGenesis Genomics Inc, Thunder Bay, ON, Canada
15:05	285	Up-regulation of Melan-A/MART-1 antigen expression during human melanoma cell differentiation A Serafino PhD^a, P Pierimarchi MD^a, G Rasi MD^a, G Lazzarino PhD^d, B Tavazzi PhD^c, F Andreola^a, L Mercuri^a, P Sinibaldi-Vallebona PhD^b ^aSection of Molecular Medicine, Institute of Neurobiology and Molecular Medicine, National Research Council, Italy, ^bDepartment of Experimental Medicine and Biochemical Science - University of Rome “Tor Vergata”and, Rome, Italy, ^cInstitute of Biochemistry and Clinical Biochemistry, Catholic University of Rome “Sacro Cuore”, Rome, Italy, ^dDepartment of Chemical Science, Laboratory of Biochemistry, University of Catania, Catania, Italy
15:20	286	High sensitivity detection of tumor cells in peripheral blood of carcinoma patients by a reverse transcription PCR method B Gutierrez, H Zieglschmid PhD, W Albert PhD, O Böcher PhD AdnaGen AG, Langenhagen, Germany
15:35	287	Method for identifying autoantigens relevant to cancer F Madrid MD^a,b, H Alansari^a,b, N Tang^a,b, RL Karvonen^c ^aDepartment of Internal Medicine, Wayne State University, Detroit, MI, United States, ^bKarmanos Cancer Institute, Wayne State University, Detroit, MI, United States, ^cScience Institute for Biomedical Research, Birmingham, MI, United States

Poster Presentations

Number	Title / Authors / Affiliations
288	Methylenetetrahydrorefolate reductase gene expression and folate concentration in adjacent mucosa are associated with outcome of colorectal cancer patients E Odin BSc, Y Wettergren PhD, G Carlsson MD PhD, A Termini MD, B Gustavsson MD PhD Department of General Surgery, Sahlgrenska University Hospital/Östra, Göteborg, Sweden
289	Low expression of the folate-associated genes RFC-1 and FPGS correlates with lack of a DCC splice variant in mucosa adjacent to carcinomas in colorectal cancer patients Y Wettergren PhD^a, E Odin BSc^a, S Nilsson PhD^b, R Willén MD PhD^c, G Carlsson MD PhD^a, L Larsson MD^a, B Gustavsson MD PhD^a ^aDepartment of General Surgery, ^bDepartment of Clinical Genetics; Sahlgrenska University Hospital/Östra, Göteborg University, Göteborg, Sweden, ^cDepartment of Pathology and Cytology, Uppsala University Hospital, Uppsala, Sweden
290	Enhanced non-invasive detection of colorectal cancer and polyps by automated processing of stable exfoliated epithelial cells on stool surface IK O'Neill PhD^a, HJ O'Neill^a, P Aebi^b, A Loktionov PhD^a ^aMicroprevention Tests Ltd, Cambridge, United Kingdom, ^bTECAN Schweiz AG, Mannedorf, Switzerland
291	NUCB2 – SEREX-identified antigen in gastric adenocarcinoma – possible reasons for immunogenicity Z Slucka MSc^a, A Line PhD^a, J Miltins BSc^a, K Silina^a, A Stengrevics MD^b, R Bruvere MD^a, N Grabuseva MSc^a ^aBiomedical Research and Study Centre, University of Latvia, Riga, Latvia, ^bLatvian Oncology Center, Riga, Latvia
292	Is Fascin-1 an additional prognostic marker for invasive breast carcinoma? G Tong MD^a, HT Yee MD PhD^a, O Hernandez MD^a, L Chiriboga PhD^a, H Levine MD^a New York University Medical Center, New York, NY, United States
293	Identification of a panel of tumor-associated antigens from cDNA libraries displayed on lambda bacteriophage E Pavoni Dr^a, A Pucci Dr^a, P Vaccaro PhD^a, G Monteriù Dr^a, E Beghetto Dr^a, S Barca Dr^b, M Cianfriglia Dr^b, E Cortesi MD Prof^c, RA Virdis MD^c, F Felici PhD Prof^a,d, O Minenkova PhD^a ^aKenton Laboratories, Pomezia, Italy, ^bLaboratorio di Immunologia, Reparto Immunologia dei Tumori, Istituto Superiore di Sanità, Rome, Italy, ^cOncologia Medica, Dipartimento di Medicina Sperimentale e Patologia, Facolta di Medicina e Chirurgia, Università di Roma "La Sapienza", Rome, Italy, ^dDipartimento di Scienze Microbiologiche, Genetiche e Molecolari, Università di Messina, Messina, Italy
294	Expression and Amplification of HER3 Gene in Primary Breast Carcinomas R Naidu PhD^a, AW Norhanom PhD^b, MK Kutty MD^c ^aDepartment of Molecular Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, ^bInstitute of Biological Sciences, University of Malaya, Kuala Lumpur, Malaysia, ^cSeri Kota Medical Center, Klang, Selangor, Malaysia
295	MAGE-E1 Expression in Non-Small Cell Lung Cancer S Ito MD, H Katakura MD, K Takenaka MD, H Oyanagi MD, K Yanagihara MD, F Tanaka MD, H Wada MD Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan
296	The assessment of serum levels of sICAM-1, CEA and CA19-9 in colon cancer patients pre- & post-operation AR Andalib PhD, J Hashemi-Niya MSc, G Safaie PhD, SH Babazadeh MD Immunology Department, Isfahan Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
297	GalNAc DSLc4-enriched Microdomain Involved Cell Adhesion and Signal Transduction through Carbohydrate-Carbohydrate Interaction in Human Renal Carcinoma TOS-1 Cells M Satoh MD^a, A Ito MD^a, S Saito^a, H Aoki^a, K Mitsuzuka^a, K Numahata^a, S Tokuyama^a, Y Arai^a, S Hakomori^b ^aDivision of Urology, Graduate School of Medicine, Tohoku University, Sendai, Japan, ^bPacific Northwest Research Institute, Seattle, WA, United States
298	Expression of cyclooxygenase-2 in kidney, bladder, prostate and testicular cancer M Matsuyama MD PhD^a,d, R Yoshimura MD PhD^a, K Kuratsukuri MD PhD^a, Y Takemoto MD PhD^a, K Tsuchida MD PhD^a, Y Kawahito MD PhD^b, H Sano MD PhD^c, M Kawamura MD PhD^d, T Nakatani MD PhD^a (a)Department of Urology, Osaka City University Graduate School of Medicine; (b)Department of Internal Medicine, Kyoto Prefectural University of Medicine; (c)Department of Internal Medicine, Hyogo College of Medicine; (d)Department of Urology, PL Hospital
299	Expression of pancreatitis-associated protein (PAP) in human pancreatic cancer: analyis in serum, pancreatic juice and tissues Y Motoo MD, H Mouri MD, K Ohtsubo MD, Y Yamaguchi MD, H Watanabe MD, N Sawabu MD Department of Internal Medicine and Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
420	Cell morphology in field effects and in sites distant from malignant tumors HE Nieburgs MD Department of Pathology, University of Massachusetts Medical School, Worcester, MA, United States